Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWG3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,532
Award facts
- Contract value 100% obligated
- $47,531.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $47,531.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion federal acquisition strategy designed to ensure consistent pharmaceutical supply to military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense pharmaceutical supply chain, with the underlying PPV-G GEN V contract providing a $499,999,999 ceiling through December 31, 2036. The company's product portfolio encompasses an extensive range of pharmaceuticals and medical consumables, including specialty medications, biologics, vaccines, and emergency supplies. Through its regional prime vendor role, DMS Pharmaceutical Group is positioned to fulfill diverse and specialized pharmaceutical requirements across military medical facilities globally, with this BOTOX delivery order representing one of numerous awards issued by the agency's Medical Supply Chain division to support recurring federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQWG3?
SPE2DR26FQWG3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FQWG3 worth?
The government has obligated $47,532 on SPE2DR26FQWG3.
Is contract SPE2DR26FQWG3 an order under another contract?
Yes. SPE2DR26FQWG3 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWG3 competed?
The extent of competition for SPE2DR26FQWG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award